Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new 'Study Status' entry was added to the record history (revision v3.3.3) on 2025-12-16. The 'HHS Vulnerability Disclosure' link was removed (revision v3.3.2) on 2025-12-01.SummaryDifference0.4%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe Record History page now lists a 'Study Status' change and shows an updated latest entry dated 2025-12-01 (version 40).SummaryDifference0.3%

- Check47 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page history.SummaryDifference0.1%

- Check54 days agoChange DetectedThe government funding notice banner was removed from the page. No trial data or record details were changed.SummaryDifference0.5%

- Check69 days agoChange DetectedThe new version updates the study status. It also revises the Contacts/Locations section, altering location entries and contact details.SummaryDifference0.1%

- Check97 days agoChange Detected- Updated the page to include a government-operating-status notice and a new version tag (v3.2.0), replacing the old v3.1.0.SummaryDifference10%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.